BAE Systems Says Order Flow Is Strong; Backs Guidance
By Anthony O. Goriainoff
BAE Systems said order flow on new and existing programs remains strong, and backed its guidance for the year.
The U.K. defense-and-aerospace group said Monday that renewals and progress within its pipeline was strong and underpinned expectations for good top-line growth in the coming years.
BAE said it was experiencing another year of strong order intake with over 30 billion pounds ($36.68 billion) booked in the year to date.
The company said its high order flow reflected continued customer confidence.
In August, the board raised its sales growth guidance to a 5% to 7% range from previous guidance of 3% to 5%, compared with sales of GBP23.26 billion in 2022. Underlying earnings before interest and taxes are now seen rising by between 6% and 8%, up from a range of 4% to 6%. Growth for underlying earnings per share guidance is seen within a 10% to 12% range.
"We are delivering another year of good sales and earnings growth, together with strong cash flow generation," Chief Executive Charles Woodburn said.
Write to Anthony O. Goriainoff at anthony.orunagoriainoff@dowjones.com
(END) Dow Jones Newswires
November 13, 2023 02:38 ET (07:38 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track